HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigeaki Ohno Selected Research

Keratoconjunctivitis

3/2021Disinfectant potential in inactivation of epidemic keratoconjunctivitis-related adenoviruses by potassium peroxymonosulfate.
12/2019Assessment of clinical signs associated with adenoviral epidemic keratoconjunctivitis cases in southern Japan between 2011 and 2014.
9/2007Anti-adenoviral effect of anti-HIV agents in vitro in serotypes inducing keratoconjunctivitis.
1/2007Antiadenoviral effect of the alpha 5 beta 1 integrin receptor ligand, GRGDSP peptide, in serotypes that cause acute keratoconjunctivitis.
4/2005Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis--a double-blind, randomized, phase-2 clinical trial.
11/2002Tear osteopontin levels in patients with allergic conjunctival diseases.
10/2002Adenovirus detected by polymerase chain reaction in multidose eyedrop bottles used by patients with adenoviral keratoconjunctivitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigeaki Ohno Research Topics

Disease

32Inflammation (Inflammations)
10/2020 - 06/2003
30Uveitis
05/2022 - 01/2002
12Diabetic Retinopathy (Retinopathy, Diabetic)
09/2014 - 06/2002
11Sarcoidosis (Schaumann Disease)
05/2022 - 11/2003
7Behcet Syndrome (Behcet's Syndrome)
04/2021 - 12/2003
7Keratoconjunctivitis
03/2021 - 10/2002
6Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
05/2022 - 12/2006
6Conjunctival Diseases
07/2020 - 11/2002
6Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
07/2020 - 11/2002
6Infections
01/2019 - 10/2002
5Genetic Predisposition to Disease (Genetic Predisposition)
01/2022 - 12/2005
5Low Tension Glaucoma
01/2016 - 10/2008
5Retinal Detachment (Retinal Detachments)
05/2010 - 05/2004
5Epiretinal Membrane (Epiretinal Membranes)
05/2010 - 06/2002
4Disease Susceptibility (Diathesis)
01/2022 - 12/2005
4Cataract (Cataracts)
08/2012 - 06/2006
4Conjunctivitis
01/2011 - 10/2002
4Ischemia
09/2007 - 11/2002
4Myopia
09/2007 - 12/2006
4Retinoblastoma (Glioblastoma, Retinal)
08/2007 - 08/2005
3Panuveitis
01/2019 - 01/2016
3Choroidal Neovascularization
04/2008 - 01/2002
3Pneumonia (Pneumonitis)
12/2006 - 11/2003
2Tuberculosis (Tuberculoses)
04/2021 - 01/2015
2Cross Infection (Nosocomial Infection)
03/2021 - 12/2007
2White Dot Syndromes
06/2019 - 07/2007
2Cicatrix (Scar)
06/2019 - 05/2012
2Chorioretinitis
06/2019 - 05/2012
2Drug-Related Side Effects and Adverse Reactions
01/2019 - 01/2003
2Atopic Dermatitis (Atopic Eczema)
09/2016 - 07/2006
2Virus Diseases (Viral Diseases)
01/2016 - 06/2011
2Hemorrhage
03/2013 - 12/2006
2Tubulointerstitial nephritis and uveitis
03/2013 - 12/2006
2Retinal Vasculitis
09/2012 - 02/2002
2Autoimmune Diseases (Autoimmune Disease)
01/2011 - 06/2009
2Neoplasms (Cancer)
11/2007 - 11/2005
2Retinal Diseases
10/2007 - 08/2007
2Pterygium
09/2007 - 07/2007
2Proliferative Vitreoretinopathy
08/2007 - 01/2004
2Macular Degeneration (Age-Related Maculopathy)
06/2006 - 01/2002

Drug/Important Bio-Agent (IBA)

15EndotoxinsIBA
01/2014 - 06/2003
10CytokinesIBA
01/2021 - 01/2002
9Adrenal Cortex Hormones (Corticosteroids)IBA
11/2016 - 02/2002
8Retinaldehyde (Retinal)IBA
06/2019 - 06/2006
7NF-kappa B (NF-kB)IBA
04/2010 - 01/2004
7Proteins (Proteins, Gene)FDA Link
02/2006 - 12/2002
6Ophthalmic Solutions (Eye Drops)IBA
07/2020 - 10/2002
6Prednisolone (Predate)FDA LinkGeneric
06/2019 - 08/2004
6LipopolysaccharidesIBA
01/2014 - 06/2003
5Pharmaceutical PreparationsIBA
07/2020 - 01/2003
4Biomarkers (Surrogate Marker)IBA
04/2021 - 01/2010
4Antiviral Agents (Antivirals)IBA
03/2021 - 04/2003
4Infliximab (Remicade)FDA Link
01/2019 - 12/2003
4DNA (Deoxyribonucleic Acid)IBA
01/2011 - 12/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2010 - 03/2007
4LigandsIBA
12/2009 - 10/2004
4AntibodiesIBA
12/2009 - 05/2004
4Glycoproteins (Glycoprotein)IBA
07/2007 - 11/2003
3SteroidsIBA
07/2020 - 03/2011
3Anti-Allergic Agents (Antiallergic Agents)IBA
07/2020 - 03/2011
3Interleukin-10 (Interleukin 10)IBA
03/2017 - 08/2010
3Peptides (Polypeptides)IBA
12/2016 - 10/2003
3Bevacizumab (Avastin)FDA Link
03/2013 - 05/2010
3HLA-B Antigens (HLA-B)IBA
02/2012 - 12/2005
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2010 - 01/2004
3astaxanthine (astaxanthin)IBA
04/2008 - 06/2003
3Fluorescein (Funduscein)FDA LinkGeneric
12/2007 - 07/2007
3Cyclin D1IBA
07/2007 - 05/2004
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2006 - 11/2003
3Proliferating Cell Nuclear Antigen (PCNA)IBA
03/2006 - 05/2004
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2006 - 12/2003
3Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2006 - 08/2004
2HLA Antigens (Human Leukocyte Antigens)IBA
05/2022 - 01/2022
2Sirolimus (Rapamycin)FDA Link
10/2020 - 11/2016
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2016 - 07/2007
2Amino Acid Transport System X-AG (Glutamate Transporter)IBA
01/2016 - 03/2011
2N- (3,5- bis(trifluoromethyl)phenyl)- 5- chloro- 2- hydroxybenzamideIBA
09/2014 - 01/2012
2Olopatadine Hydrochloride (Patanol)FDA Link
12/2012 - 09/2012
2HLA-DRB1 Chains (HLA DRB1)IBA
10/2012 - 09/2010
2AntigensIBA
09/2012 - 06/2006
2Toll-Like Receptor 2IBA
03/2011 - 12/2009
2HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2010 - 08/2007
2Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2009 - 10/2008
2Toll-Like Receptor 4IBA
12/2009 - 10/2008
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2008 - 12/2007
2Carotenoids (Carotene)IBA
04/2008 - 02/2006
2LuteinIBA
12/2007 - 06/2006
2ErythropoietinFDA Link
11/2007 - 10/2007
2Erythropoietin Receptors (Erythropoietin Receptor)IBA
10/2007 - 11/2006
2p38 Mitogen-Activated Protein KinasesIBA
09/2007 - 01/2006
2Cidofovir (Vistide)FDA Link
09/2007 - 01/2004
2Advanced Glycation End ProductsIBA
07/2007 - 03/2007
2OsteopontinIBA
01/2007 - 11/2002
2Macrophage Migration-Inhibitory FactorsIBA
07/2006 - 01/2002

Therapy/Procedure

14Therapeutics
07/2020 - 01/2003
6Vitrectomy
01/2015 - 11/2006
3Intravitreal Injections
03/2013 - 09/2008
2Lasers (Laser)
11/2016 - 12/2008
2Aftercare (After-Treatment)
12/2008 - 03/2006
2Light Coagulation
03/2007 - 07/2005